Biotech Earnings: Winners and Losers | Business and Finance News

Biotech’s Q1 earnings reveal a wild ride: 14 companies beat revenue forecasts by 13%, lifting the sector 12% as stocks rally. Natera soared with $700M in revenue—up 39% YoY—and shattered its own record processing over 1M units. Meanwhile, United Therapeutics stumbled, missing targets by 2% and losing 6% in value. Moderna dominated with 260% YoY growth, crushing estimates by 55% and boosting its stock 50%. Regeneron and Amgen also delivered strong results, proving some biotechs are thriving despite the sector’s volatility. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/addd2c2e92838802